Table 2 List of papers included in analysis, arranged in date order (most recent first) with PubMed PMID reference numbers

[10]

Health- and vision-related quality of life in patients receiving infliximab therapy for Behcet uveitis

2013

23314623

[11]

Secukinumab in the treatment of noninfectious uveitis: results of three randomized, controlled clinical trials

23290985

[12]

Clinical background comparison of patients with and without ocular inflammatory attacks after initiation of infliximab therapy

2012

23053631

[13]

Multicenter study of infliximab for refractory uveoretinitis in Behçet disease

22652845

[14]

A single infliximab infusion vs corticosteroids for acute panuveitis attacks in Behçet’s disease: a comparative 4-week study

2011

21097877

[15]

One year study of efficacy and safety of infliximab in the treatment of patients with ocular and neurological Behçet’s disease refractory to standard immunosuppressive drugs

19859715

[16]

Azathioprine in severe uveitis of Behçet’s disease

2010

20665749

[17]

Comparison of infliximab versus ciclosporin during the initial 6-month treatment period in Behçet disease

20545993

[18]

Effects of atorvastatin and lisinopril on endothelial dysfunction in patients with Behçet’s disease

20704623

[19]

Pimecrolimus versus placebo in genital aphthous ulcers of Behcet’s disease: a randomized double-blind controlled trial

20704622

[20]

Rituximab in intractable ocular lesions of Behcet’s disease; randomized single-blind control study (pilot study)

19692382

[21]

Colchicine versus placebo in Behçet’s disease: randomized, double-blind, controlled crossover trial

2009

19076988

[22]

Effectiveness and safety of endovascular aneurysm treatment in patients with vasculo-Behçet disease

19717547

[23]

Low-dose natural human interferon-alpha lozenges in the treatment of Behçet’s syndrome

19842735

[24]

Randomized trial of pimecrolimus cream plus colchicine tablets versus colchicine tablets in the treatment of genital ulcers in Behçet’s disease

19434815

[25]

Relationship between periodontal parameters and Behçet’s disease and evaluation of different treatments for oral recurrent aphthous stomatitis

19320802

[26]

The close association between dental and periodontal treatments and oral ulcer course in behcet’s disease: a prospective clinical study

19060462

[27]

Treatment with levamisole and colchicine can result in a significant reduction of IL-6, IL-8 or TNF-α level in patients with mucocutaneous type of Behcet’s disease

19597921

[28]

Behçet’s disease: comparing 3 decades of treatment response at the National Eye Institute

2008

18929351

[29]

Infliximab effects compared to conventional therapy in the management of retinal vasculitis in Behçet disease

18711463

[30]

Interrelated modulation of endothelial function in Behcet’s disease by clinical activity and corticosteroid treatment

2007

17845731

[31]

A double-blind trial of depot corticosteroids in Behçet’s syndrome

2006

17067433

[32]

Lactobacilli lozenges in the management of oral ulcers of Behçet’s syndrome

16923135

[33]

Oral zinc sulfate in the treatment of Behcet’s disease: a double blind cross-over study

16263779

[34]

Colchicine and benzathine penicillin in the treatment of Behçet disease: a case comparative study

2005

16409899

[35]

Short-term trial of etanercept in Behçet’s disease: a double blind, placebo controlled study

16321889

[36]

Vitrectomy for persistent panuveitis in Behçet’s disease

15630733

[37]

Abdominal aortic aneurysm in Behçet’s disease: new treatment options for an old and challenging problem

2004

15079762

[38]

Differential efficacy of human recombinant interferon-α2a on ocular and extraocular manifestations of behçet disease: results of an open 4-center trial

14996689

[39]

Infliximab for recurrent, sight-threatening disease in Adamantiades-Behcet disease

15055270

[40]

Clinical study on therapeutic effect of acupuncture on Behcet’s disease

2003

14719295

[41]

Efficacy of rebamipide as adjunctive therapy in the treatment of recurrent oral aphthous ulcers in patients with Behçet’s disease: a randomised, double-blind, placebo-controlled study

12928692

[42]

Evaluation of the effect of acetazolamide on cystoid macular oedema in patients with Behcet’s disease

12918754

[43]

Dapsone in Behçet’s disease: a double-blind, placebo-controlled, cross-over study

2002

12568631

[44]

A double-blind trial of colchicine in Behçet’s syndrome

2001

12081158

[45]

Mycophenolate mofetil is ineffective in the treatment of mucocutaneous Adamantiades-Behçet’s disease

11935432

[46]

Short-term chlorambucil for refractory uveitis in Behcet’s disease

11710724

[47]

Ciclosporin Microemulsion Preconcentrate Treatment of Patients With Behçet’s Disease

1999

11752821

[48]

Effects of interferon-alpha2a treatment on serum levels of tumor necrosis factor-alpha, tumor necrosis factor-alpha2 receptor, interleukin-2, interleukin-2 receptor, and E-selectin in Behçet’s disease

10482480

[49]

The Use of Sucralfate Suspension in the Treatment of Oral and Genital Ulceration of Behchet Disease

10328192

[50]

Thalidomide in the Treatment of the Mucocutaneous Lesions of the Behcet Syndrome

1998

10651074

[51]

Treatment of Adamantiades-Behçet disease with systemic interferon alfa

9722733

[52]

Effect of prophylactic benzathine penicillin on mucocutaneous symptoms of Behçet’s disease

1996

9499327

[53]

Interferon alfa-2a in the treatment of Behçet’s disease

8829493

[54]

A phase II study of FK506 (tacrolimus) on refractory uveitis associated with Behçet’s disease and allied conditions

1995

8594659

[55]

Inefficacy of azapropazone in the acute arthritis of Behçet’s syndrome: a randomized, double blind, placebo controlled study

7586783

[56]

Clinical experience with thalidomide in the management of severe oral and genital ulceration in conditions such as Behçet’s disease: use of neurophysiological studies to detect thalidomide neuropathy

1994

7864692

[57]

Systemic interferon alpha 2b treatment in Behçet’s syndrome

7932420

[58]

Visual prognosis in patients with Behçet’s disease receiving colchicine, systemic corticosteroid or cyclosporin

7970549

[59]

Low dose cyclosporin A versus pulsed cyclophosphamide in Behçet’s syndrome: a single masked trial

1992

1390495

[60]

Desensitization by autologous saliva and Behçet’s disease

1991

1913022

[61]

Effect of cyclosporine A on the hearing loss in Behçet’s disease

1771312

[62]

Inefficacy of Topical Alpha Interferon in the Treatment of Oral Ulcers of Behcet’s Syndrome: a Randomized Double Blind Trial

2058987

[63]

Long-term effects of cyclophosphamide and colchicine treatment in Behçet’s disease

2064258

[64]

Treatment of Behçet disease with indomethacin

1993568

[65]

A controlled trial of azathioprine in Behcet’s syndrome

1990

2404204

[66]

Topical alpha interferon in the treatment of oral ulcers in Behçet’s syndrome: a preliminary report

2189624

[67]

Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in behcet’s disease

1989

2566048

[68]

Evaluation of conventional therapy versus cyclosporine A in Behçet’s syndrome

1988

3044474

[69]

Treatment with aciclovir does not affect orogenital ulcers in Behcet’s syndrome: a randomised double-blind trial

3381269